204 related articles for article (PubMed ID: 16520412)
1. Advanced glycation end products activate a chymase-dependent angiotensin II-generating pathway in diabetic complications.
Koka V; Wang W; Huang XR; Kim-Mitsuyama S; Truong LD; Lan HY
Circulation; 2006 Mar; 113(10):1353-60. PubMed ID: 16520412
[TBL] [Abstract][Full Text] [Related]
2. Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease.
Huang XR; Chen WY; Truong LD; Lan HY
J Am Soc Nephrol; 2003 Jul; 14(7):1738-47. PubMed ID: 12819233
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of high glucose induced angiotensin II production in rat vascular smooth muscle cells.
Lavrentyev EN; Estes AM; Malik KU
Circ Res; 2007 Aug; 101(5):455-64. PubMed ID: 17626897
[TBL] [Abstract][Full Text] [Related]
4. Pathobiological role of advanced glycation endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy.
Yoon YW; Kang TS; Lee BK; Chang W; Hwang KC; Rhee JH; Min PK; Hong BK; Rim SJ; Kwon HM
Exp Mol Med; 2008 Aug; 40(4):398-406. PubMed ID: 18779652
[TBL] [Abstract][Full Text] [Related]
5. RAGE mediates accelerated diabetic vein graft atherosclerosis induced by combined mechanical stress and AGEs via synergistic ERK activation.
Li Y; Liu S; Zhang Z; Xu Q; Xie F; Wang J; Ping S; Li C; Wang Z; Zhang M; Huang J; Chen D; Hu L; Li C
PLoS One; 2012; 7(4):e35016. PubMed ID: 22496883
[TBL] [Abstract][Full Text] [Related]
6. The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus.
Hori O; Yan SD; Ogawa S; Kuwabara K; Matsumoto M; Stern D; Schmidt AM
Nephrol Dial Transplant; 1996; 11 Suppl 5():13-6. PubMed ID: 9044300
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications.
Wautier JL; Wautier MP; Schmidt AM; Anderson GM; Hori O; Zoukourian C; Capron L; Chappey O; Yan SD; Brett J
Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7742-6. PubMed ID: 8052654
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end-products activate the renin-angiotensin system through the RAGE/PI3-K signaling pathway in podocytes.
Cheng CL; Tang Y; Zheng Z; Liu X; Ye ZC; Wang C; Lou TQ
Clin Invest Med; 2012 Oct; 35(5):E282. PubMed ID: 23043709
[TBL] [Abstract][Full Text] [Related]
9. Expression of receptors for advanced glycation end-products in occlusive vascular and renal disease.
Bierhaus A; Ritz E; Nawroth PP
Nephrol Dial Transplant; 1996; 11 Suppl 5():87-90. PubMed ID: 9044315
[TBL] [Abstract][Full Text] [Related]
10. Role of chymase-dependent angiotensin II formation in regulating blood pressure in spontaneously hypertensive rats.
Kirimura K; Takai S; Jin D; Muramatsu M; Kishi K; Yoshikawa K; Nakabayashi M; Mino Y; Miyazaki M
Hypertens Res; 2005 May; 28(5):457-64. PubMed ID: 16156510
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress.
Wei Q; Ren X; Jiang Y; Jin H; Liu N; Li J
BMC Cardiovasc Disord; 2013 Mar; 13():13. PubMed ID: 23497312
[TBL] [Abstract][Full Text] [Related]
12. Effect of chymase inhibitor on vascular proliferation.
Takai S; Miyazaki M
Jpn J Pharmacol; 2002 Nov; 90(3):223-7. PubMed ID: 12499576
[TBL] [Abstract][Full Text] [Related]
13. Roles of advanced glycation endproducts (AGE) and receptor for AGE on vascular smooth muscle cell growth.
Wang R; Kudo M; Yokoyama M; Asano G
J Nippon Med Sch; 2001 Dec; 68(6):472-81. PubMed ID: 11744927
[TBL] [Abstract][Full Text] [Related]
14. Local angiotensin II-generating system in vascular tissues: the roles of chymase.
Miyazaki M; Takai S
Hypertens Res; 2001 May; 24(3):189-93. PubMed ID: 11409639
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway.
Li JH; Wang W; Huang XR; Oldfield M; Schmidt AM; Cooper ME; Lan HY
Am J Pathol; 2004 Apr; 164(4):1389-97. PubMed ID: 15039226
[TBL] [Abstract][Full Text] [Related]
16. Calycosin protects HUVECs from advanced glycation end products-induced macrophage infiltration.
Xu Y; Feng L; Wang S; Zhu Q; Zheng Z; Xiang P; He B; Tang D
J Ethnopharmacol; 2011 Sep; 137(1):359-70. PubMed ID: 21669275
[TBL] [Abstract][Full Text] [Related]
17. Reduction of advanced-glycation end products levels and inhibition of RAGE signaling decreases rat vascular calcification induced by diabetes.
Brodeur MR; Bouvet C; Bouchard S; Moreau S; Leblond J; Deblois D; Moreau P
PLoS One; 2014; 9(1):e85922. PubMed ID: 24465790
[TBL] [Abstract][Full Text] [Related]
18. Chymase as a proangiogenic factor. A possible involvement of chymase-angiotensin-dependent pathway in the hamster sponge angiogenesis model.
Muramatsu M; Katada J; Hayashi I; Majima M
J Biol Chem; 2000 Feb; 275(8):5545-52. PubMed ID: 10681534
[TBL] [Abstract][Full Text] [Related]
19. The protective effect of Smilax glabra extract on advanced glycation end products-induced endothelial dysfunction in HUVECs via RAGE-ERK1/2-NF-κB pathway.
Sang HQ; Gu JF; Yuan JR; Zhang MH; Jia XB; Feng L
J Ethnopharmacol; 2014 Aug; 155(1):785-95. PubMed ID: 24953033
[TBL] [Abstract][Full Text] [Related]
20. Effects of chymostatin, a chymase inhibitor, on blood pressure, plasma and tissue angiotensin II, renal haemodynamics and renal excretion in two models of hypertension in the rat.
Roszkowska-Chojecka MM; Walkowska A; Gawryś O; Baranowska I; Kalisz M; Litwiniuk A; Martyńska L; Kompanowska-Jezierska E
Exp Physiol; 2015 Sep; 100(9):1093-105. PubMed ID: 26011164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
